Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
Tenaya Therapeutics (TNYA) Stock Price & Analysis
364 Followers
TNYA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.66 - $8.09
Previous Close$4.29
Volume60.54K
Average Volume (3M)614.27K
Market Cap
$339.97M
Enterprise Value$244.62M
Total Cash (Recent Filing)$104.64M
Total Debt (Recent Filing)$12.42M
Price to Earnings (P/E)-2.5
Beta2.67
Next Earnings
May 08, 2024EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.72
Shares Outstanding78,516,142
10 Day Avg. Volume291,758
30 Day Avg. Volume614,273
Standard Deviation0.32
R-Squared0.19
Alpha-0.00922
Financial Highlights & Ratios
Price to Book (P/B)2.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.66
Forecast
1Y Price Target
$16.40Price Target Upside278.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Tenaya Therapeutics News
Bulls Say, Bears Say
Bulls Say
Clinical Trial AdvancementsInitial data from the TN-201 program is expected to be a key potential catalyst for shares.
Financial StabilityTenaya's recent $50M equity raise extends its financial runway, offering stability as it approaches significant clinical milestones.
Strategic PartnershipsThe company is exploring pharma partnership opportunities for TN-301, which could help bolster its financial position.
Bears Say
Equity DilutionTNYA announced a public offering of 8,888,890 shares priced at $4.50 per share, which could suggest dilution of existing shares.
Financial PerformanceR&D expenses were below estimates, potentially indicating slower than expected progress in development activities.
ValuationThe net result of recent updates is a decrease in the sum-of-the-parts-based valuation to $18 from $19.
---
Ownership Overview
68.36% Insiders
15.58% Mutual Funds
6.20% Other Institutional Investors
9.85% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNYA FAQ
What was Tenaya Therapeutics’s price range in the past 12 months?
Tenaya Therapeutics lowest stock price was $1.66 and its highest was $8.09 in the past 12 months.
What is Tenaya Therapeutics’s market cap?
Currently, no data Available
When is Tenaya Therapeutics’s upcoming earnings report date?
Tenaya Therapeutics’s upcoming earnings report date is May 08, 2024 which is in 13 days.
How were Tenaya Therapeutics’s earnings last quarter?
Tenaya Therapeutics released its earnings results on Mar 18, 2024. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.434 by $0.034.
Is Tenaya Therapeutics overvalued?
According to Wall Street analysts Tenaya Therapeutics’s price is currently Undervalued.
Does Tenaya Therapeutics pay dividends?
Tenaya Therapeutics does not currently pay dividends.
What is Tenaya Therapeutics’s EPS estimate?
Tenaya Therapeutics’s EPS estimate is -$0.42.
How many shares outstanding does Tenaya Therapeutics have?
Tenaya Therapeutics has 78,516,140 shares outstanding.
What happened to Tenaya Therapeutics’s price movement after its last earnings report?
Tenaya Therapeutics reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.434. Following the earnings report the stock price went down -6.017%.
Which hedge fund is a major shareholder of Tenaya Therapeutics?
Among the largest hedge funds holding Tenaya Therapeutics’s share is RA Capital Management. It holds Tenaya Therapeutics’s shares valued at 18M.
---
Tenaya Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.40 (278.75% Upside)
$16.40 (278.75% Upside)
Blogger Sentiment
Bullish
TNYA Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $19.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 4.9%
Last 30 Days ▲ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.29%
12-Months-Change
Fundamentals
Return on Equity
-64.83%
Trailing 12-Months
Asset Growth
-38.87%
Trailing 12-Months
Company Description
Tenaya Therapeutics
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
---
TNYA Stock 12 Months Forecast
Average Price Target
$16.40
▲(278.75% Upside)
Technical Analysis
Best Analysts Covering TNYA
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+49.21%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +49.21% per trade.
---